| Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk | Sarah de Crescenzo | 12/13/19 | New York |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone | Frank Vinluan | 09/06/19 | National |
| Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step | Ben Fidler | 08/09/19 | National |
| Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More | Alex Lash | 03/22/19 | National |
| Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder | Alex Lash | 11/10/18 | New York |
| Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More | Ben Fidler | 09/28/18 | National |
| Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study | Ben Fidler | 09/24/18 | New York |
| Catabasis Scores $32M Series B Round With IPO in Sight | Ben Fidler | 11/15/13 | Boston |
